Half-year report · Q2
7716.TEDINET S100WGNK
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥39.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥77.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥8.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥6.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.3bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥7.0bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥153.8bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥158.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥156.8bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.5bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥37.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥117.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥121.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥124.0bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.6bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥32.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥599m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥41.84 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.37 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.88 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.7 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.06 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.63 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥66m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥23.7bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥23.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.7bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥363m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥39.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥39.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥10.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥401m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥23.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥23.3bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥9.2bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥415m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.1bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥38.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥38.6bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sales and redemption of investment securities inv cf | Prior1YTDDuration | 456832000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | CurrentYTDDuration | 444715000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | － | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | -669800000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -3439673000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -3303962000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 407228000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 354960000 | JPY |
| Purchase of insurance funds inv cf | Prior1YTDDuration | -51008000 | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -48217000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | 1311126000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | -23669000 | JPY |
| Other net inv cf | CurrentYTDDuration | -38393000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -3931282000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -6439803000 | JPY |
| Increase in short term loans payable fin cf | Prior1YTDDuration | 10530000 | JPY |
| Increase in short term loans payable fin cf | CurrentYTDDuration | 2002800000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Decrease in short term loans payable fin cf | CurrentYTDDuration | -2000000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 3000000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 3032980000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -250000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -1145998000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -2217037000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -2195778000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -1999859000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -2253016000 | JPY |
| Proceeds from sales of treasury stock fin cf | Prior1YTDDuration | 8485000 | JPY |
| Proceeds from sales of treasury stock fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -1447882000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -2559014000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 2251247000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -1152732000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 4159934000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -2573185000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 25972808000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 35224056000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 30132742000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 32650870000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 3975583000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 4405996000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 121176000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 142295000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 23335326000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | 9933219000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 2022635000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 3266062000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 38557243000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |